Champions Share Price

Champions Share Price

NASDAQ: CSBR | Micro Cap | Healthcare
$4.32
+$4.32 (--%) Last updated on 20 Nov, 2026 | 22:15 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Champions Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
$4.41 - $7.54
Volume
N/A
Average Traded
N/A

Champions Share Price Chart

Line chart of the Champions price trend over the selected period. The price rose overall, ranging from 4.32 to 4.32, ending at 4.32.
$0.00$0.00
L
Show Current Price
H

Champions Stock Fundamentals & Key Indicators

Market Cap
$58.94M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.08
Revenue (TTM)
$59.43B
Return On Equity (TTM)
-28.36%
Profit Margin
-1.99%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-259.26%

Champions Quarterly Profit & Loss

All figures in USD

ParticularsOct 2025Jan 2026Apr 2026Jul 2026
Revenue$15.04$16.56$13.84$15.23
Net Profit$0.27-$0.28-$0.67-$0.43
Net Profit Margin1.80%-1.69%-4.84%-2.82%
Income ChangeN/A-203.70%-139.29%35.82%

Champions Annual Profit & Loss

All figures in USD

Particulars2023202420252026
Revenue$53.87$50.16$56.94$59.43
Net Profit-$5.34-$7.28$4.70-$1.18
Net Profit Margin-9.91%-14.51%8.25%-1.99%
Income ChangeN/A-36.33%164.56%-125.11%

Champions Balance Sheet

All figures in USD Million

Particulars2026202520242023
Non Current Assets7.779.9912.4914.85
Current Assets19.2222.3613.6419.46
Total Assets26.9932.3426.1334.31
Non Current Liabilities3.04.726.497.94
Current Liabilities19.9223.8521.5421.73
Total Liabilities22.9228.5728.0429.68
Shareholders' Equity4.073.77-1.94.64

Champions Cash Flow

Annually

All figures in USD Million

Particulars2026202520242023
Operating-4.477.39-6.143.97
Investing-0.54-0.39-0.84-2.87
Financing0.10.17-0.530.01

About Champions

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services.

Champions Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$4.82
$4.32
-10.85%
Oct 2026
$4.90
$4.84
+0.62%
Sep 2026
$5.07
$4.81
-3.80%
Aug 2026
$5.11
$5.00
-12.59%
Jul 2026
$5.99
$5.72
-11.46%
Jun 2026
$5.71
$6.46
+11.38%
May 2026
$5.92
$5.80
-2.36%
Apr 2026
$5.90
$5.94
+3.13%
Mar 2026
$6.13
$5.76
-3.27%
Feb 2026
$6.83
$5.96
-18.48%
Jan 2026
$6.64
$7.30
-0.48%
Dec 2025
$6.11
$7.34
+12.58%

Champions Share Price FAQs